当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 现金流量表

华熙生物

(688363)

  

流通市值:199.17亿  总市值:199.17亿
流通股本:4.82亿   总股本:4.82亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金887,508,516.44,430,650,311.43,353,715,907.952,412,552,080.06
  收到的税费返还15,053,824.3528,084,322.5724,986,150.6615,826,940.92
  收到其他与经营活动有关的现金43,548,482.59241,717,904.3107,753,484.3467,397,801.72
  经营活动现金流入小计946,110,823.344,700,452,538.273,486,455,542.952,495,776,822.7
  购买商品、接受劳务支付的现金132,655,292.061,071,202,392.66847,703,235.74597,234,503.6
  支付给职工以及为职工支付的现金215,295,501.531,155,171,930.08915,887,663.34660,268,627.26
  支付的各项税费74,741,052.58254,128,635.22201,999,259161,984,621.64
  支付其他与经营活动有关的现金392,458,966.491,592,499,647.991,212,106,353.74857,956,812.29
  经营活动现金流出小计815,150,812.664,073,002,605.953,177,696,511.822,277,444,564.79
  经营活动产生的现金流量净额130,960,010.68627,449,932.32308,759,031.13218,332,257.91
二、投资活动产生的现金流量:
  收回投资收到的现金-128,966.58128,966.58-
  取得投资收益收到的现金1,005,657.2410,422,604.96,804,511.99946,443.22
  处置固定资产、无形资产和其他长期资产收回的现金净额4,471.12,073,945.552,250,645.551,738,491
  收到的其他与投资活动有关的现金416,456,100451,000,000331,000,00090,000,000
  投资活动现金流入小计417,466,228.34463,625,517.03340,184,124.1292,684,934.22
  购建固定资产、无形资产和其他长期资产支付的现金101,522,084.12325,677,846.28225,471,073.33151,146,165.73
  投资支付的现金13,500,00068,853,353.8142,527,00010,910,000
  支付其他与投资活动有关的现金446,456,100333,960,000243,960,00060,000,000
  投资活动现金流出小计561,478,184.12728,491,200.09511,958,073.33222,056,165.73
  投资活动产生的现金流量净额-144,011,955.78-264,865,683.06-171,773,949.21-129,371,231.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,520,0002,520,0002,520,000
  其中:子公司吸收少数股东投资收到的现金-2,520,0002,520,0002,520,000
  取得借款收到的现金66,665,000310,280,683.61217,460,125167,460,125
  筹资活动现金流入小计66,665,000312,800,683.61219,980,125169,980,125
  偿还债务支付的现金24,077,596.57202,629,200.48202,212,716.84178,126,119.18
  分配股利、利润或偿付利息支付的现金1,315,165.6156,078,754.5654,988,150.481,314,312.41
  支付其他与筹资活动有关的现金6,626,678.4356,392,125.2650,838,125.1536,452,054.28
  筹资活动现金流出小计32,019,440.61315,100,080.3308,038,992.47215,892,485.87
  筹资活动产生的现金流量净额34,645,559.39-2,299,396.69-88,058,867.47-45,912,360.87
四、汇率变动对现金及现金等价物的影响-8,475,867.363,998,656.1211,025,045.2112,791,476.54
五、现金及现金等价物净增加额13,117,746.93364,283,508.6959,951,259.6655,840,142.07
  加:期初现金及现金等价物余额977,775,917.06613,492,408.37613,492,408.37613,492,408.37
  期末现金及现金等价物余额990,893,663.99977,775,917.06673,443,668.03669,332,550.44
补充资料:
  净利润-291,148,370.39-220,803,434.47
  资产减值准备-108,053,142.71-41,390,475.33
  固定资产和投资性房地产折旧-282,926,828.17-135,862,616.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-282,926,828.17-135,862,616.19
  无形资产摊销-27,260,609.23-13,262,602.74
  长期待摊费用摊销-33,176,989.05-17,470,579.81
  处置固定资产、无形资产和其他长期资产的损失--217,334.91-445,465.9
  固定资产报废损失-2,160,447.35-865,841.33
  公允价值变动损失--19,623,286.8--556,788.66
  财务费用-2,418,325.03--8,393,065.66
  投资损失-5,471,394.65-5,773,140.64
  递延所得税-19,678,789.89-15,508,744.11
  其中:递延所得税资产减少-20,003,609.71-15,715,976.84
    递延所得税负债增加--324,819.82--207,232.73
  存货的减少-162,150,697.82-38,106,528.73
  经营性应收项目的减少--38,988,841.48--60,123,174.28
  经营性应付项目的增加--327,967,578.94--258,782,439.7
  其他--5,283,388.57-3,366,403.06
  不涉及现金收支的投资和筹资活动金额其他项目-41,489,473.44-30,171,435.5
  现金的期末余额-977,775,917.06-669,332,550.44
  减:现金的期初余额-613,492,408.37-613,492,408.37
  现金及现金等价物的净增加额-364,283,508.69-55,840,142.07
公告日期2026-04-302026-04-232025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑